UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043482
Receipt number R000049643
Scientific Title Developmental changes of brain activity related with moral judgment -fMRI study-
Date of disclosure of the study information 2021/04/01
Last modified on 2023/09/04 09:00:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Developmental changes of brain activity related with moral judgment -fMRI study-

Acronym

Developmental changes of brain activity related with moral judgment -fMRI study-

Scientific Title

Developmental changes of brain activity related with moral judgment -fMRI study-

Scientific Title:Acronym

Developmental changes of brain activity related with moral judgment -fMRI study-

Region

Japan


Condition

Condition

typical developmental children/adults

Classification by specialty

Adult Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Neural network information is measured by DTI (Diffusion tensor imaging), resting-state brain activity information is measured by rs-fMRI (resting-state fMRI), and brain activity information during moral judgment is measured by fMRI.

Basic objectives2

Others

Basic objectives -Others

Information about these brain activities from children, adults, and aged persons will clarify a relationship between brain structures and brain activities about the neutral situation and moral judgment from the viewpoint of development.
Because these results will provide pieces of evidence to moral education, there is a possibility that this study will contribute to constructing a stable society for all generations.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Age group comparison of BOLD signal changes measured by fMRI during moral judgment

Key secondary outcomes

1. Anti-social personality measured by Japanese ver. of Dark Triad Dirty Dozen
2. personality measured by Japanese ver. of Ten Item Personality Inventory
3. the motivations assumed to underlie forgiving from the Japanese Transgression-Related Interpersonal Motivations Scale
4. Apologizable scale from the Japanese Proclivity to Apologize Measure (J-PAM)
5. Forgiveness scale from the Japanese Trait Forgivingness Scale (J-TFS)
6. IQ from WISC-IV or WAIS-IV
7. Loneliness scale from Japanese UCLA Loneliness Scale
8. brain volumes from VBM
9. neural fiber information from DTI
10. Default mode brain activity from rs-fMRI


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

moral judgment to visually presented stimuli(child group)

Interventions/Control_2

moral judgment to visually presented stimuli(adult group)

Interventions/Control_3

moral judgment to visually presented stimuli(aged group)

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

12 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy individuals who meet the following criteria are eligible.
1. 12-15 years old (mainly junior high school students), 18-24 years old (mainly university students), and 60-65 years old at the time of obtaining consent
2. Those who have obtained consent for this study by signing a consent form by themselves or a substitute.

Key exclusion criteria

Those who meet any of the following conditions will not be included in this study:
1. history of head trauma with disturbance of consciousness for more than 5 minutes
2. History of organic brain disease.
3. History of psychiatric disorders in life history.
4. memory or current symptoms of substance abuse (e.g., alcohol)
5. taking central nervous system agonists (psychotropic drugs, antiepileptic drugs, sleeping pills, etc.)
6. history of clouding of consciousness, convulsive seizures except for febrile convulsions
7. chronic headache symptoms
8. color blindness
9. Those who are unable to undergo an MRI examination.
10. If the researcher judges that the subject is inappropriate for other reasons.

Target sample size

72


Research contact person

Name of lead principal investigator

1st name Yasuomi
Middle name
Last name Ouchi

Organization

Hamamatsu University School of Medicine

Division name

Biofunctional Imaging

Zip code

431-3192

Address

1-20-1,Handayama, Higashi-ku, Hamamatsu, Shizuoka, Japan

TEL

053-435-2466

Email

ouchi@hama-med.ac.jp


Public contact

Name of contact person

1st name Hirotoshi
Middle name
Last name Hiraishi

Organization

Hamamatsu University School of Medicine

Division name

Biofunctional Imaging

Zip code

431-3192

Address

1-20-1,Handayama, Higashi-ku, Hamamatsu, Shizuoka, Japan

TEL

053-435-2466

Homepage URL


Email

hiraishi@hama-med.ac.jp


Sponsor or person

Institute

Hamamatsu University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

JST

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Hamamatsu Medical Photonics Foundation

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research Ethics Committee, Hamamatsu University School of Medicine

Address

1-20-1,Handayama, Higashi-ku, Hamamatsu, Shizuoka, Japan

Tel

053-435-2680

Email

rinri@hama-med.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

No.167/C036

Org. issuing International ID_1

Hamamatsu Medical Photonics Foundation

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

浜松医科大学(静岡県)   Hamamatsu University School of Medicine (Shizuoka Pref.)
浜松PET診断センター(静岡県)Hamamatsu PET Imaging Center (Shizuoka Pref.)


Other administrative information

Date of disclosure of the study information

2021 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 02 Month 24 Day

Date of IRB

2021 Year 02 Month 24 Day

Anticipated trial start date

2021 Year 03 Month 15 Day

Last follow-up date

2026 Year 02 Month 26 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Psychological tests and fMRI measurements have been performed on groups of 60-65 yrs and 20-25 yrs in this year term.


Management information

Registered date

2021 Year 03 Month 01 Day

Last modified on

2023 Year 09 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049643


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name